Codes / ICD10CM / M06.069

M06.069 Rheumatoid arthritis without rheumatoid factor, unspecified knee

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Rheumatoid arthritis without rheumatoid factor, unspecified knee

Summary

Rheumatoid arthritis without rheumatoid factor, unspecified knee is a chronic inflammatory disorder affecting the knee joint. It is characterized by symmetric joint pain, swelling, and stiffness, with no detectable rheumatoid factor in blood tests. The condition can lead to joint damage and functional impairment over time if left untreated. Diagnosis relies on clinical evaluation, imaging, and exclusion of other inflammatory arthritides.

Causes

The exact etiology is unclear but involves an autoimmune response where the body’s immune system mistakenly attacks joint tissues. Genetic and environmental factors may contribute to disease development, though specific triggers remain unclear. No single cause has been identified.

Risk Factors

  • Genetic predisposition (e.g., HLA-DR4 alleles).
  • Age: Typically onset between 30–50 years.
  • Sex: More common in women.
  • Smoking: Increases risk and disease severity.
  • Family history of autoimmune diseases.

Symptoms

  • Joint pain, swelling, and stiffness in the knee.
  • Symmetric joint involvement (if other joints are affected).
  • Morning stiffness lasting >30 minutes.
  • Fatigue and low-grade fever.
  • Reduced range of motion in the knee.

Diagnosis

Diagnosis relies on clinical evaluation, including joint examination, symptom duration, and exclusion of other conditions. Blood tests check for inflammatory markers, and imaging (e.g., X-rays or MRI) assesses joint damage. The absence of rheumatoid factor distinguishes this from seropositive rheumatoid arthritis.

Treatment Options

Treatment focuses on reducing inflammation, relieving pain, and preserving joint function. Options include disease-modifying antirheumatic drugs (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), physical therapy, and in severe cases, surgery. Early intervention is key to slowing disease progression.

Prognosis and Follow-Up

Prognosis varies; some patients experience mild symptoms, while others develop significant joint damage. Regular follow-up with a rheumatologist is essential to monitor disease activity, adjust treatment, and prevent complications. Long-term management may be required to maintain mobility and quality of life.

Complications

  • Joint deformity or instability.
  • Reduced mobility and functional impairment.
  • Increased risk of osteoporosis.
  • Cardiovascular complications due to chronic inflammation.

Lifestyle & Prevention

  • Maintain a healthy weight to reduce knee stress.
  • Engage in low-impact exercise (e.g., swimming) to preserve joint function.
  • Avoid smoking, as it worsens disease severity.
  • Use assistive devices (e.g., braces) to support the knee during activity.

When to Seek Professional Help

Seek care if knee pain, swelling, or stiffness persists for more than a few weeks, or if symptoms worsen despite home care. Prompt evaluation is crucial to initiate treatment and prevent joint damage.

Tips for Medical Coders

Document the absence of rheumatoid factor and specify the knee as the affected joint. Ensure clinical notes support the diagnosis, including symptom duration, joint involvement, and exclusion of other conditions. Use this code for unspecified knee involvement; specify laterality (e.g., right or left) if documented.

Medical Policies and Guidelines

Related policies from health plans

Book a walkthrough

M06.069 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.